Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

Share Price is delayed by 15 minutes
Get Live Data
174.00    0.00 (0.00%)
Bid:
166.00
Ask:
182.00
Spread: 16.00 (9.639%)
Market Cap: £104.96m
JZCP Live PriceLast checked at - London Stock Exchange

Intraday Jz Capital Share Chart

US Acquisitions

25 Nov 2014 13:00

RNS Number : 9508X
JZ Capital Partners Ltd
25 November 2014
 



 

 

JZ CAPITAL PARTNERS EXPANDS PORTFOLIO WITH TWO U.S. ACQUISITIONS

25 November 2014

JZ Capital Partners Limited (LSE:JZCP.L or "JZCP"), the London listed private equity fund that invests in high quality US and European microcap companies, has expanded its US vertical portfolio by making two acquisitions alongside Edgewater Funds LP ("Edgewater").

JZCP and Edgewater invested $1.6 million each to acquire Action Products Marketing Corporation and ConShield Technologies Incorporated ("APMCS"), an infrastructure rehabilitation company headquartered in Johnston, Iowa. The company specialises in formulating and selling cementitious manhole and pipe rehabilitation products and provides the associated equipment used for application itself. The acquisition of APMCS is the third for the water infrastructure sub-vertical and the sixth for the water business overall.

JZCP and Edgewater also invested $1.31 million each to acquire PPM Information Solutions, Inc. ("PPMIS"), an anaesthesia billing software and service company. PPMIS operates two business lines, generating revenue from its proprietary billing and practice management software platform used by anaesthesia practices and other billing companies, and by providing outsourced medical billing services to anaesthesia practices. The acquisition of PPMIS is the third for the Bolder Healthcare Solutions vertical.

David Zalaznick, JZCP's Founder and Investment Adviser, commented:"Both acquisitions demonstrate the scope and expansion of our US portfolio and the strength of our investment pipeline. We are confident in the growth prospects of both companies and look forward to assisting them in reaching their full potential.

Both APMCS and PPMIS hold strong positions in their respective sectors and offer considerable opportunities to expand product range to appeal to their customers. We look forward to working with our co-investor Edgewater and the management teams of both companies over the coming years."

 

Ends

 

For further information:

 

Ed Berry / Kit Dunford +44 (0) 20 3727 1143

FTI Consulting

 

David Zalaznick +1 212 572 0800

Jordan/Zalaznick Advisers, Inc.

 

Andrew Maiden +44 (0) 1481 745368

JZ Capital Partners

 

About JZCP

 

JZCP is a London and Channel Islands listed private equity fund which invests in high quality US and European microcap companies. Its objective is to achieve a superior overall return comprised of a current yield and significant capital appreciation. JZCP receives investment advice from Jordan/Zalaznick Advisers, Inc. ("JZAI") which is led by David Zalaznick and Jay Jordan. They have worked together for 30 years and are supported by teams of investment professionals in New York, Chicago, London and Madrid. JZAI's experts work with the existing management of microcap companies to help build better businesses, create value and deliver strong returns for investors. JZCP also invests in mezzanine loans, first and second lien investments and other publicly traded securities. For more information please visit www.jzcp.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLELFLZFFZFBV
Date   Source Headline
3rd Jul 20124:47 pmRNSAnnual General Meeting
3rd Jul 20123:25 pmRNSResults of Second General Meeting
3rd Jul 201211:43 amRNSResults of First General Meeting
7th Jun 20129:36 amRNSNet Asset Value(s)
1st Jun 20124:55 pmRNSHolding(s) in Company
22nd May 201212:31 pmRNSDirector/PDMR Shareholding
18th May 20127:02 amRNSProposed admission and other strategic initiatives
18th May 20127:01 amRNSDividend declaration
18th May 20127:00 amRNSFull Year Results 2011
17th May 20127:00 amRNSNet Asset Value(s)
27th Apr 20129:07 amRNSNet Asset Value(s)
17th Apr 20124:04 pmRNSNotice of Results - Replacement
13th Apr 20128:57 amRNSNotice of Results
24th Feb 201210:05 amRNSNew Accounting Ref Date
23rd Feb 20129:23 amRNSNet Asset Value(s)
25th Jan 20125:02 pmRNSHolding(s) in Company
25th Jan 20122:17 pmRNSTotal Voting Rights
20th Jan 20124:49 pmRNSHolding(s) in Company
19th Jan 20125:31 pmRNSDirector/PDMR Shareholding
19th Jan 20125:30 pmRNSDirector/PDMR Shareholding
19th Jan 20125:29 pmRNSDirector/PDMR Shareholding
19th Jan 20125:27 pmRNSDirector/PDMR Shareholding
17th Jan 20129:22 amRNSNet Asset Value(s)
16th Jan 201211:46 amRNSHolding(s) in Company
10th Jan 20123:33 pmRNSHolding(s) in Company
29th Dec 201110:03 amRNSHolding(s) in Company
28th Dec 20119:34 amRNSNet Asset Value(s)
22nd Dec 20115:23 pmRNSDirector/PDMR Shareholding
22nd Dec 20119:43 amRNSHolding(s) in Company
20th Dec 20117:00 amRNSJZCP Q3 Interim Management Statement
14th Dec 201111:23 amRNSHolding(s) in Company
6th Dec 20111:58 pmRNSHolding(s) in Company
2nd Dec 20117:00 amRNSCompletes Sale of Wound Care Holdings LLC
1st Dec 20119:17 amRNSConversion of Securities
23rd Nov 20114:17 pmRNSNet Asset Value(s)
31st Oct 20119:52 amRNSNet Asset Value(s)
25th Oct 20112:55 pmRNSDisposal
20th Oct 20114:28 pmRNSHolding(s) in Company
19th Oct 20112:02 pmRNSDividend Declaration
18th Oct 20113:58 pmRNSNet Asset Value(s)
18th Oct 20117:00 amRNSInterim Results 2011
10th Oct 201110:48 amRNSHolding(s) in Company
5th Oct 20119:25 amRNSHolding(s) in Company
27th Sep 20119:28 amRNSHolding(s) in Company
16th Sep 20118:58 amRNSNotice of Interim Results
25th Aug 20117:00 amRNSConversion of Shares
12th Aug 20118:18 amRNSNet Asset Value(s)
18th Jul 20117:00 amRNSAcquisition and realisation of Investments
13th Jul 20118:30 amRNSNet Asset Value(s)
28th Jun 20115:01 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.